PTPRB and macular retinal edema: Early studies in patients with diabetes with macular edema have shown that administration of AKB-9778 (a vascular endothelial protein tyrosine phosphatase that promotes Tie-2 receptor activation) for 4 weeks reduced macular edema and improved vision, without demonstrating any safety concerns [50].